Schwann cell O-GlcNAc glycosylation is required for myelin maintenance and axon integrity

Journal of Neuroscience

Volumn 36, Issue 37, 2016, Pages 9633-9646

  Kim, Sungsu ^a   Maynard, Jason C ^b   Sasaki, Yo ^a   Strickland, Amy ^a   Sherman, Diane L ^c   Brophy, Peter J ^c   Burlingame, Alma L ^b   Milbrandt, Jeffrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CMT; O GlcNAc; OGT; Periaxin; Schwann cell; Tomacula

Indexed keywords

MYELIN; N ACETYLGLUCOSAMINE; PERIAXIN; PROTEIN; UNCLASSIFIED DRUG; GLUCOSE; MBP PROTEIN, MOUSE; MEMBRANE PROTEIN; MYELIN BASIC PROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; NERVE PROTEIN; O-GLCNAC TRANSFERASE; TUBULIN;

ADULT; AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; GLUCOSE METABOLISM; GLYCOSYLATION; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOUSE; MYELIN SHEATH; MYELINATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; RAT; SCHWANN CELL; SCIATIC NERVE; TOMACULOUS DEMYELINATING PERIPHERAL NEUROPATHY; WESTERN BLOTTING; ACTION POTENTIAL; ANIMAL; AXON; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NERVE CONDUCTION; NEUROLOGIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ACETYLGLUCOSAMINE; ACTION POTENTIALS; ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AXONS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOSYLATION; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEIN; MYELIN SHEATH; N-ACETYLGLUCOSAMINYLTRANSFERASES; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; PROTEOMICS; SCIATIC NERVE; TUBULIN;

EID: 84987850225     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1235-16.2016     Document Type: Article

References (40)

1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 11:274–280.
2. Baker PR, Chalkley RJ (2014) MS-viewer: a web-based spectral viewer for proteomics results. Mol Cell Proteomics 13:1392–1396.
3. Beirowski B, Babetto E, Golden JP, Chen YJ, Yang K, Gross RW, Patti GJ, Milbrandt J (2014) Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance. Nat Neurosci 17:1351–1361.
4. Bond MR, Hanover JA (2013) O-GlcNAc cycling: a link between metabolism and chronic disease. Annu Rev Nutr 33:205–229.
5. Bond MR, Hanover JA (2015) A little sugar goes a long way: the cell biology of O-GlcNAc. J Cell Biol 208:869–880.
6. Cheng X, Hart GW (2001) Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J Biol Chem 276:10570–10575.
7. Corfas G, Velardez MO, Ko CP, Ratner N, Peles E (2004) Mechanisms and roles of axon-Schwann cell interactions. J Neurosci 24:9250–9260.
8. Court FA, Sherman DL, Pratt T, Garry EM, Ribchester RR, Cottrell DF, Fleetwood-Walker SM, Brophy PJ (2004) Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431:191–195.
9. Dytrych L, Sherman DL, Gillespie CS, Brophy PJ (1998) Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J Biol Chem 273:5794–5800.
10. Feltri ML, D’antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L (1999) P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann N Y Acad Sci 883:116–123.
11. Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA (2012) Glycolytic oligodendrocytes maintain myelin and longterm axonal integrity. Nature 485:517–521.
12. Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:497–508.
13. Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A, Brophy PJ (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26:523–531.
14. Goebbels S, Oltrogge JH, Wolfer S, Wieser GL, Nientiedt T, Pieper A, Ruhwedel T, Groszer M, Sereda MW, Nave KA (2012) Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol Med 4:486–499.
15. Hahne H, Sobotzki N, Nyberg T, Helm D, Borodkin VS, van Aalten DM, Agnew B, Kuster B (2013) Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. J Proteome Res 12:927–936.
16. Halim A, Westerlind U, Pett C, Schorlemer M, Rüetschi U, Brinkmalm G, Sihlbom C, Lengqvist J, Larson G, Nilsson J (2014) Assignment of saccharide identities through analysis of oxonium ion fragmentation profiles in LC-MS/MS of glycopeptides. J Proteome Res 13:6024–6032.
17. Hart GW, Akimoto Y (2009) The O-GlcNAc modification. In: Essentials of glycobiology Chap 18 (Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, eds). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
18. Maddala R, Skiba NP, Lalane R, Sherman DL, Brophy PJ, Rao PV (2011) Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. Dev Biol 357:179–190.
19. Nave K-A (2010) Myelination and the trophic support of long axons. Nat Rev Neurosci 11:275–283.
20. Norrmén C, Figlia G, Lebrun-Julien F, Pereira JA, Trötzmüller M, Köfeler HC, Rantanen V, Wessig C, van Deijk AL, Smit AB, Verheijen MH, Rüegg MA, Hall MN, Suter U (2014) mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells. Cell Rep 9:646–660.
21. O’Donnell N, Zachara NE, Hart GW, Marth JD (2004) Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 24:1680–1690.
22. Ozcan S, Andrali SS, Cantrell JE (2010) Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 1799:353–364.
23. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Möbius W, Nave KA, Werner HB (2011) Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369–16386.
24. Pooya S, Liu X, Kumar VB, Anderson J, Imai F, Zhang W, Ciraolo G, Ratner N, Setchell KDR, Yoshida Y, Jankowski MP, Dasgupta B (2014) The tumour suppressor LKB1 regulates myelination through mitochondrial metabolism. Nat Commun 5:4993.
25. Renouil M, Stojkovic T, Jacquemont ML, Lauret K, Boué P, Fourmaintraux A, Randrianaivo H, Tallot M, Mignard D, Roelens P, Tabailloux D, Bernard R, Cartault F, Chane-Thien E, Dubourg O, Ferrer X, Sole G, Fournier E, Latour P, Lacour A, et al (2013) [Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): clinical, electrophysiological and genetic analysis of 24 patients]. Rev Neurol (Paris) 169:603–612.
26. Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD (2000) Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 68:483–488.
27. Scherer SS, Xu YT, Bannerman PG, Sherman DL, Brophy PJ (1995) Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during. Development 121:4265–4273.
28. Shafi R, Iyer SP, Ellies LG, O’Donnell N, Marek KW, Chui D, Hart GW, Marth JD (2000) The O-GlcNAc transferase gene resides on the X chromo some and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 97:5735–5739.
29. Shen Y-AA, Chen Y, Dao DQ, Mayoral SR, Wu L, Meijer D, Ullian EM, Chan JR, Lu QR (2014) Phosphorylation of LKB1/Par-4 establishes Schwann cell polarity to initiate and control myelin extent. Nat Commun 5:4991.
30. Sherman DL, Brophy PJ (2000) A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J Biol Chem 275:4537–4540.
31. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ (2001) Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677–687.
32. Sherman DL, Wu LMN, Grove M, Gillespie CS, Brophy PJ (2012) Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. J Neurosci 32:9419–9428.
33. Smith RS, Koles ZJ (1970) Myelinated nerve fibers: computed effect of myelin thickness on conduction velocity. Am J Physiol 219:1256–1258.
34. Trinidad JC, Barkan DT, Gulledge BF, Thalhammer A, Sali A, Schoepfer R, Burlingame AL (2012) Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol Cell Proteomics 11:215–229.
35. Viader A, Golden JP, Baloh RH, Schmidt RE, Hunter DA, Milbrandt J (2011) Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci 31:10128–10140.
36. Viader A, Sasaki Y, Kim S, Strickland A, Workman CS, Yang K, Gross RW, Milbrandt J (2013) Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron 77:886–898.
37. Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL (2006) O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol Cell Proteomics 5:923–934.
38. Wu LM, Williams A, Delaney A, Sherman DL, Brophy PJ (2012) Increasing internodal distance in myelinated nerves accelerates nerve conduction to a flat maximum. Curr Biol CB 22:1957–1961.
39. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE (2003) O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115:715–725.
40. Zhu Y, Liu T-W, Cecioni S, Eskandari R, Zandberg WF, Vocadlo DJ (2015) O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains. Nat Chem Biol 11:319–325.